英文名稱 |
中文名稱 |
CAS號 |
操作 |
Canertinib |
|
267243-28-7 |
詳細(xì)
|
AEE788 (NVP-AEE788) |
|
497839-62-0 |
詳細(xì)
|
Pyrotinib dimaleate |
|
1397922-61-0 |
詳細(xì)
|
RTC-5 |
|
1423077-49-9 |
詳細(xì)
|
EGFR-IN-7 |
|
2267329-76-8 |
詳細(xì)
|
Thalidomide-PEG2-C2-NH2 TFA |
|
2097509-36-7 |
詳細(xì)
|
BI-4020 |
|
2664214-60-0 |
詳細(xì)
|
Gefitinib hydrochloride |
|
184475-55-6 |
詳細(xì)
|
Varlitinib (ARRY334543) |
|
845272-21-1 |
詳細(xì)
|
JI-101 |
|
900573-88-8 |
詳細(xì)
|
AP26113 |
|
1197958-12-5 |
詳細(xì)
|
Mavelertinib |
|
1776112-90-3 |
詳細(xì)
|
(S,R,S)-AHPC-PEG4-NH2 hydrochloride |
|
2064292-52-8 |
詳細(xì)
|
Pomalidomide-PEG1-C2-COOH |
|
2139348-60-8 |
詳細(xì)
|
(S,R,S)-AHPC-PEG3-NH2 |
|
2010159-56-3 |
詳細(xì)
|
Almonertinib |
|
1899921-05-1 |
詳細(xì)
|
Pomalidomide-amino-PEG3-NH2 hydrochloride |
|
2380273-75-4 |
詳細(xì)
|
NVP-BHG712 isomer |
|
2245892-85-5 |
詳細(xì)
|
Pomalidomide-PEG3-C2-NH2 TFA |
|
2414913-97-4 |
詳細(xì)
|
Trastuzumab deruxtecan |
|
1826843-81-5 |
詳細(xì)
|
Pomalidomide-PEG4-C2-NH2 hydrochloride |
|
2357105-92-9 |
詳細(xì)
|
WZ8040 |
|
1214265-57-2 |
詳細(xì)
|
Lapatinib-d4 |
|
1184263-99-7 |
詳細(xì)
|
Icotinib Hydrochloride |
|
1204313-51-8 |
詳細(xì)
|
AST-1306 TsOH |
|
1050500-29-2 |
詳細(xì)
|
Thalidomide-O-amido-PEG3-C2-NH2 TFA |
|
1957236-21-3 |
詳細(xì)
|
AG-18 |
|
118409-57-7 |
詳細(xì)
|
VH032-PEG5-C6-Cl |
|
1799506-06-1 |
詳細(xì)
|
Alflutinib mesylate |
|
2130958-55-1 |
詳細(xì)
|
JND3229 |
|
2260886-64-2 |
詳細(xì)
|
123C4 |
|
2034159-30-1 |
詳細(xì)
|
MRT00033659 |
|
1401731-54-1 |
詳細(xì)
|
Pomalidomide 4'-PEG2-azide |
|
2271036-45-2 |
詳細(xì)
|
Lapatinib ditosylate monohydrate |
|
388082-78-8 |
詳細(xì)
|
Nazartinib |
|
1508250-71-2 |
詳細(xì)
|
Gefitinib-based PROTAC 3 |
|
2230821-27-7 |
詳細(xì)
|
Antiviral agent 24 |
|
23661-03-2 |
詳細(xì)
|
(S,R,S)-AHPC-phenol-C4-NH2 dihydrochloride |
|
2376990-26-8 |
詳細(xì)
|
(S,R,S)-AHPC-PEG5-COOH |
|
2172820-14-1 |
詳細(xì)
|
BMS-690514 |
|
859853-30-8 |
詳細(xì)
|
AP-III-a4 |
|
1177827-73-4 |
詳細(xì)
|
MX69 |
|
1005264-47-0 |
詳細(xì)
|
Pomalidomide-PEG2-COOH |
|
2140807-17-4 |
詳細(xì)
|
OSI-420 free base |
|
183321-86-0 |
詳細(xì)
|
AZ7550 Mesylate |
|
2319837-99-3 |
詳細(xì)
|
AG-1478 |
|
153436-53-4 |
詳細(xì)
|
Pirodavir |
|
124436-59-5 |
詳細(xì)
|
CP-724714 |
|
537705-08-1 |
詳細(xì)
|
AZD3759 |
|
1626387-80-1 |
詳細(xì)
|
Thalidomide-O-amido-C3-COOH |
|
2308035-51-8 |
詳細(xì)
|
Thalidomide-O-C6-COOH |
|
2169266-69-5 |
詳細(xì)
|
Thalidomide-Piperazine-PEG1-COOH |
|
2731007-11-5 |
詳細(xì)
|
ARRY-380 analog |
|
937265-83-3 |
詳細(xì)
|
GSK682753A |
|
1334294-76-6 |
詳細(xì)
|
(S,R,S)-AHPC-(C3-PEG)2-C6-Cl |
|
1835705-61-7 |
詳細(xì)
|
Thalidomide-O-amido-C4-NH2 TFA |
|
1799711-25-3 |
詳細(xì)
|
Zipalertinib |
|
1661854-97-2 |
詳細(xì)
|
Thalidomide-piperazine-Boc |
|
2222114-64-7 |
詳細(xì)
|
PD153035 hydrochloride |
|
153436-54-5 |
詳細(xì)
|
Mutant EGFR inhibitor |
|
1421373-62-7 |
詳細(xì)
|
(E/Z)-AG490 |
|
134036-52-5 |
詳細(xì)
|
Thalidomide-NH-C6-NH2 TFA |
|
2093386-51-5 |
詳細(xì)
|
EGFR-IN-11 |
|
2463200-44-2 |
詳細(xì)
|
AST-1306 |
|
897383-62-9 |
詳細(xì)
|
AZD-9291 (Mesylate) |
|
1421373-66-1 |
詳細(xì)
|
NIBR189 |
|
1599432-08-2 |
詳細(xì)
|
EAI045 |
|
1942114-09-1 |
詳細(xì)
|
PD168393 |
|
194423-15-9 |
詳細(xì)
|
Lazertinib |
|
1903008-80-9 |
詳細(xì)
|
Simotinib |
|
944258-89-3 |
詳細(xì)
|
Thalidomide-O-amido-C6-NH2 TFA |
|
1950635-14-9 |
詳細(xì)
|
Thalidomide-NH-PEG3-propionic acid |
|
2138440-82-9 |
詳細(xì)
|
Compound 56 |
|
171745-13-4 |
詳細(xì)
|
Pleconaril |
|
153168-05-9 |
詳細(xì)
|
Almonertinib mesylate |
|
2134096-06-1 |
詳細(xì)
|
Thalidomide-O-amido-C3-PEG3-C1-NH2 |
|
1799711-29-7 |
詳細(xì)
|
ONO-AE3-208 |
|
402473-54-5 |
詳細(xì)
|
HLM006474 |
|
353519-63-8 |
詳細(xì)
|
(S,R,S)-AHPC-PEG2-N3 |
|
2010159-45-0 |
詳細(xì)
|
RG 13022 |
|
136831-48-6 |
詳細(xì)
|
Thalidomide 4'-ether-alkylC2-amine hydrochloride |
|
2341840-99-9 |
詳細(xì)
|
Pomalidomide-PEG1-C2-N3 |
|
2271036-44-1 |
詳細(xì)
|
Thalidomide-NH-C4-NH-Boc |
|
2093388-52-2 |
詳細(xì)
|
UniPR129 |
|
1639159-47-9 |
詳細(xì)
|
Pomalidomide-amino-PEG5-NH2 hydrochloride |
|
2421217-05-0 |
詳細(xì)
|
Hydrocotarnine |
|
550-10-7 |
詳細(xì)
|
Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 TFA |
|
2435572-49-7 |
詳細(xì)
|
Rupintrivir |
|
223537-30-2 |
詳細(xì)
|
Teslexivir hydrochloride |
|
1075281-70-7 |
詳細(xì)
|
TAS0728 |
|
2088323-16-2 |
詳細(xì)
|
Thalidomide-O-amido-C8-NH2 TFA |
|
1950635-16-1 |
詳細(xì)
|
Golgicide A-2 |
|
1394285-50-7 |
詳細(xì)
|
Tyrphostin AG30 |
|
122520-79-0 |
詳細(xì)
|
Pomalidomide-PEG4-C-COOH |
|
2097938-44-6 |
詳細(xì)
|
EAI001 |
|
892772-75-7 |
詳細(xì)
|
PKI-166 |
|
187724-61-4 |
詳細(xì)
|
Rezivertinib |
|
1835667-12-3 |
詳細(xì)
|
ML401 |
|
1597489-14-9 |
詳細(xì)
|
Theliatinib |
|
1353644-70-8 |
詳細(xì)
|
NSC689857 |
|
241127-79-7 |
詳細(xì)
|